(Q40631860)
Statements
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect (English)
Shawn G Clouthier
Kenneth R Cooke
Kathleen P Lowler
Chen Liu
Kevin Connolly
James L M Ferrara
1 September 2003